Guting, Jenelyn .
HRN: 12-21-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
CEFUROXIME 500MG (TAB)
11/23/2023
11/30/2023
PO
500mg
BID X 7 Days
S/P D & C
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes